)

Bio-Techne (TECH) investor relations material
Bio-Techne Morgan Stanley 23rd Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Strategic positioning and growth drivers
Core business is a global leader in reagents for life science research, with significant investments in automation, spatial biology, and cell therapy over the past decade.
Automation (ProteinSimple), spatial biology (RNAscope, COMET), and cell therapy now account for 45% of revenue, up from 30% pre-COVID, reflecting strong above-market growth.
90% of revenue is recurring, primarily from consumables and services, supporting profitability and resilience.
Cell therapy business has rapidly grown, with GMP proteins and strong positioning in regenerative medicine, supported by investments in manufacturing and partnerships.
Divestiture of Exosome Diagnostics aligns focus on core capabilities and growth vectors, reallocating resources to higher-potential areas.
Recent performance and market dynamics
Achieved 3% growth in the most recent quarter, in line with forecasts; spatial biology underperformed due to delayed instrument shipments, while China delivered its best growth in three years.
Pharma segment saw double-digit growth, outperforming expectations, but is expected to moderate due to ongoing tariff and pricing uncertainties.
U.S. academic market exposure is limited, with NIH funding representing a small portion of revenue; academic consumables have remained flat despite funding constraints.
China and broader Asia show improving sentiment and gradual recovery, with expectations for a return to double-digit growth over the next decade.
Biotech remains uncertain due to funding challenges, while large pharma continues to drive recovery and growth.
Product portfolio and competitive landscape
Core reagents business is mature, with stable growth and healthy competition, especially in antibodies and proteins.
ProteinSimple instrumentation platforms (Maurice, Simple Western, Simple Plex) drive productivity and double-digit consumables growth, with significant market penetration potential.
Spatial biology leadership is anchored by RNAscope and the COMET instrument, offering unique capabilities for simultaneous RNA and protein detection.
Cell therapy segment benefits from high-quality GMP proteins and strong customer relationships, particularly in regenerative medicine.
Next Bio-Techne earnings date

Next Bio-Techne earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage